200406-75-3

Upstream product

• 200406-74-2 [11-(3-Methoxy-2,5,6-tris-methoxymethoxy-phenyl)-undec-1-ynyl]-trimethyl-silane 
• 74-88-4 methyl iodide 
• 3117-03-1 2,5-dimethoxyquinone 
• 13239-13-9 2,5-dimethoxyhydroquinone 
• 87746-52-9 1,4-dimethoxy-2,5-di(methoxymethyloxy)benzene 
• 174228-72-9 4-Methoxy-2,5-bis-methoxymethoxy-phenol 
• 174228-73-0 1-Methoxy-2,4,5-tris-methoxymethoxy-benzene 
• 200406-73-1 3-(9-Bromo-nonyl)-1-methoxy-2,4,5-tris-methoxymethoxy-benzene 

Downstream Products

• 200406-77-5 1-Methoxy-2,4,5-tris-methoxymethoxy-6-methyl-3-pentadec-10-ynyl-benzene 
• 200406-78-6 1-Methoxy-2,4,5-tris-methoxymethoxy-6-methyl-3-((Z)-pentadec-10-enyl)-benzene 
• 200406-79-7 maesanin 
• 200406-76-4 1-Methoxy-2,4,5-tris-methoxymethoxy-6-methyl-3-undec-10-ynyl-benzene 

Relevant academic research and scientific papers

Synthesis of cytotoxic maesaquinone bearing a 2,5-dihydroxy-6-methyl-1,4-benzoquinone nucleus

A synthesis of maesaquinone [2,5-dihydroxy-3-(Z)-10'-pentadecenyl-6-methyl-1,4-benzoquinone] has been achieved in nine steps starting from 1,4,5-trimethoxymethyloxy-2-methoxybenzene which can be readily obtained by successive deprotection and MOM protection of one methoxyl group of 2,5-dimethoxy-1,4-benzoquinone.